Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2015 Q1- Text added to 2015 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Good
|
New words:
adult, American, BOSON, cholestatic, confident, death, decided, decompensated, EU, FASB, fibrosing, fully, healthy, Johnson, Knight, long, lost, MAA, ofatumumab, Pennsylvania, pharmacokinetic, portal, potent, profile, protease, rare, revocation, rilpivirine, SigmaPharm, Society, strength, syndrome, transplantation, velpatasvir, volunteer, voucher
Valuein 2015 Q1 filing- Value in 2015 Q2 filing
Original filings
Filing view